FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1714841803> ?p ?o ?g. }

• W1714841803 abstract "Eye movement disorders may affect over 70% of stroke patients. These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty moving the eyes appropriately. The resulting functional disabilities include a loss of depth perception, reduced hand-to-eye co-ordination, marked difficulties with near tasks and reading and reduced ability to scan the visual environment. They can also impact on the effectiveness of rehabilitation therapy. There are a wide variety of different treatment interventions proposed for eye movement disorders after stroke. However, in the past, there has been a lack of evidence specific to the impact of interventions on the functional outcome of patients with stroke.To determine the effects of interventions for eye movement disorders on functional ability following stroke.We searched the Cochrane Stroke Group Trials Register (February 2011), the Cochrane Eyes and Vision Group Trials Register (December 2009) and nine electronic bibliographic databases including CENTRAL (The Cochrane Library 2009, Issue 4), MEDLINE (1950 to December 2009), EMBASE (1980 to December 2009), CINAHL (1982 to December 2009), AMED (1985 to December 2009), and PsycINFO (1967 to December 2009). We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts.Randomised trials in adults after stroke where the intervention was specifically targeted at improving the eye movement disorder or improving the ability of the participant to cope with the eye movement disorder. The primary outcome was functional ability in activities of daily living. Secondary outcomes included functional ability in extended activities of daily living, eye movement measures, balance, falls, depression or anxiety, discharge destination or residence after stroke, quality of life and social isolation, adverse events, and death.Two authors independently screened abstracts, extracted data and appraised trials. We undertook assessment of methodological quality for allocation concealment, blinding of outcome assessor, method of dealing with missing data, and other potential sources of bias.Two studies (28 participants but only five were people with stroke) met the inclusion criteria and were included in this review. Both studies investigated pharmacological interventions for disorders of eye movement in patients with stroke. It was not appropriate to pool data and we were not able to draw conclusions from these studies. We found no other randomised studies which investigated interventions for disorders of eye movement in patients with stroke.There is insufficient evidence to reach conclusions about the effectiveness of interventions for patients with eye movement disorders after stroke. High quality research in the form of well-designed randomised trials are urgently required." @default.
• W1714841803 created "2016-06-24" @default.
• W1714841803 creator A5007858050 @default.
• W1714841803 creator A5009947077 @default.
• W1714841803 creator A5012716882 @default.
• W1714841803 creator A5044417394 @default.
• W1714841803 creator A5047139038 @default.
• W1714841803 creator A5047497748 @default.
• W1714841803 creator A5057125595 @default.
• W1714841803 creator A5057347443 @default.
• W1714841803 creator A5066137422 @default.
• W1714841803 creator A5073259289 @default.
• W1714841803 creator A5077648364 @default.
• W1714841803 date "2011-10-05" @default.
• W1714841803 modified "2023-10-16" @default.
• W1714841803 title "Interventions for disorders of eye movement in patients with stroke" @default.
• W1714841803 cites W1595184853 @default.
• W1714841803 cites W1967974729 @default.
• W1714841803 cites W1969341881 @default.
• W1714841803 cites W1980435400 @default.
• W1714841803 cites W1987462291 @default.
• W1714841803 cites W2019476028 @default.
• W1714841803 cites W2023879879 @default.
• W1714841803 cites W2026051038 @default.
• W1714841803 cites W2027800209 @default.
• W1714841803 cites W2030520970 @default.
• W1714841803 cites W2089128573 @default.
• W1714841803 cites W2104085366 @default.
• W1714841803 cites W2114808153 @default.
• W1714841803 cites W2125890869 @default.
• W1714841803 cites W2137627454 @default.
• W1714841803 cites W2151854438 @default.
• W1714841803 cites W2154016331 @default.
• W1714841803 cites W2161537254 @default.
• W1714841803 cites W2164108971 @default.
• W1714841803 cites W4236551477 @default.
• W1714841803 cites W4243535214 @default.
• W1714841803 cites W4250276382 @default.
• W1714841803 doi "https://doi.org/10.1002/14651858.cd008389.pub2" @default.
• W1714841803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21975780" @default.
• W1714841803 hasPublicationYear "2011" @default.
• W1714841803 type Work @default.
• W1714841803 sameAs 1714841803 @default.
• W1714841803 citedByCount "25" @default.
• W1714841803 countsByYear W17148418032014 @default.
• W1714841803 countsByYear W17148418032015 @default.
• W1714841803 countsByYear W17148418032016 @default.
• W1714841803 countsByYear W17148418032017 @default.
• W1714841803 countsByYear W17148418032018 @default.
• W1714841803 countsByYear W17148418032019 @default.
• W1714841803 countsByYear W17148418032020 @default.
• W1714841803 countsByYear W17148418032021 @default.
• W1714841803 countsByYear W17148418032022 @default.
• W1714841803 crossrefType "journal-article" @default.
• W1714841803 hasAuthorship W1714841803A5007858050 @default.
• W1714841803 hasAuthorship W1714841803A5009947077 @default.
• W1714841803 hasAuthorship W1714841803A5012716882 @default.
• W1714841803 hasAuthorship W1714841803A5044417394 @default.
• W1714841803 hasAuthorship W1714841803A5047139038 @default.
• W1714841803 hasAuthorship W1714841803A5047497748 @default.
• W1714841803 hasAuthorship W1714841803A5057125595 @default.
• W1714841803 hasAuthorship W1714841803A5057347443 @default.
• W1714841803 hasAuthorship W1714841803A5066137422 @default.
• W1714841803 hasAuthorship W1714841803A5073259289 @default.
• W1714841803 hasAuthorship W1714841803A5077648364 @default.
• W1714841803 hasBestOaLocation W17148418032 @default.
• W1714841803 hasConcept C118487528 @default.
• W1714841803 hasConcept C118552586 @default.
• W1714841803 hasConcept C127413603 @default.
• W1714841803 hasConcept C141071460 @default.
• W1714841803 hasConcept C153050134 @default.
• W1714841803 hasConcept C168563851 @default.
• W1714841803 hasConcept C17744445 @default.
• W1714841803 hasConcept C1862650 @default.
• W1714841803 hasConcept C199539241 @default.
• W1714841803 hasConcept C27415008 @default.
• W1714841803 hasConcept C2776478404 @default.
• W1714841803 hasConcept C2778818304 @default.
• W1714841803 hasConcept C2779473830 @default.
• W1714841803 hasConcept C2779549880 @default.
• W1714841803 hasConcept C2780645631 @default.
• W1714841803 hasConcept C2781145037 @default.
• W1714841803 hasConcept C71924100 @default.
• W1714841803 hasConcept C78519656 @default.
• W1714841803 hasConcept C79544238 @default.
• W1714841803 hasConcept C99508421 @default.
• W1714841803 hasConceptScore W1714841803C118487528 @default.
• W1714841803 hasConceptScore W1714841803C118552586 @default.
• W1714841803 hasConceptScore W1714841803C127413603 @default.
• W1714841803 hasConceptScore W1714841803C141071460 @default.
• W1714841803 hasConceptScore W1714841803C153050134 @default.
• W1714841803 hasConceptScore W1714841803C168563851 @default.
• W1714841803 hasConceptScore W1714841803C17744445 @default.
• W1714841803 hasConceptScore W1714841803C1862650 @default.
• W1714841803 hasConceptScore W1714841803C199539241 @default.
• W1714841803 hasConceptScore W1714841803C27415008 @default.
• W1714841803 hasConceptScore W1714841803C2776478404 @default.
• W1714841803 hasConceptScore W1714841803C2778818304 @default.
• W1714841803 hasConceptScore W1714841803C2779473830 @default.
• W1714841803 hasConceptScore W1714841803C2779549880 @default.

• next